The Chronicle Herald -- With human clinical trials beginning soon, Immunovaccine Inc. officials in Halifax are about to pitch their therapeutic cancer vaccine before some of the world’s most influential investors. “It is a major transition to go from doing the research to actually going into clinical trials,” Randal Chase, the president and chief executive officer, said Thursday in an interview.
